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doi:10.1016/j.jtcvs.2003.11.042618 The Journal of Thoracic and CardioTreatment of functional ischemic mitral regurgitation (MR) at the timeof coronary revascularization remains a challenge. In spite of manyrecent contributions in this area, debate still rages over the optimaltreatment of ischemic mitral insufficiency in the setting of infarctedmyocardium. As the level of attention to this pathophysiologicprocess has increased significantly in the past few years, the quality
of available data has risen substantially. In this issue of the Journal, Mallidi and
colleagues1 offer interesting data that advance the discussion on this topic. The
fundamental and as yet unanswered problem that surgeons are faced with is the
following: When should we intervene on functional MR at the time of coronary
artery bypass grafting (CABG), or, in other words, when should we attempt to make
a silk purse out of a sow’s ear?
Some important issues need to be reviewed before the question at hand can be
profitably examined. Craig Miller, who has added considerably to this field, crys-
tallized the nomenclature for ischemic MR, which had previously suffered from lack
of uniformity. As he succinctly pointed out in an editorial in the Journal in 2001,
“functional IMR. . .can be due to one of the following reasons: (1) simple annular
dilatation (secondary to left ventricular [LV] enlargement), which causes incom-
plete mitral leaflet coaptation associated with Carpentier type I (normal) leaflet
motion; (2) local LV remodeling with papillary muscle displacement producing
apical tethering or tenting of the leaflets (with Carpentier type III-b restricted
systolic leaflet motion); or (3) both mechanisms.”2
As surgeons, we are challenged by the knowledge that the presence of ischemic
MR is associated with poorer outcomes in many different clinical scenarios. Patient
survival after myocardial infarction and after percutaneous coronary intervention is
reduced commensurate with the degree of ischemic MR.3,4 Similarly, Harris and
associates5 reported that intervention for ischemic mitral insufficiency at the time of
CABG was especially beneficial to those patients with reduced ejection fractions.
Such information might prompt some to adopt an aggressive policy of treating
ischemic MR in the setting of left ventricular dysfunction. In contrast, Tolis and
coworkers6 and Duarte and associates7 have both reported series that show that
revascularization alone can suffice in the presence of functional MR. However, it
should be noted that the study by Duarte and associates7 focused on patients with
preserved ventricular function. Perhaps such “good” patients might not obtain
enough benefit from mitral repair to warrant the small additional risk of a concom-
itant valve procedure. Meanwhile, in the series by Tolis and coworkers,6 90% of the
patients had trace or mild MR. This study did not target the larger patient subset with
moderate MR with which we are concerned.
In the current article Mallidi and colleagues1 carefully create matched cohorts of
patients undergoing CABG with mild-to-moderate MR versus no MR. The analysis
demonstrated equivalent late survival but decreased event-free survival and func-
tional class in the MR group. The authors conclude that consideration should be
given to repairing moderate MR in selected patients to improve long-term quality of
life. Although this is new information, several small but important details must be
examined as we consider its significance. One weakness is the lack of echocardio-
graphic classification of MR, primarily because of the use of ventriculography alone
for detection of MR. Only a small percentage of the patients had preoperative
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Lechocardiography, a more reliable and reproducible method
for quantifying MR.8 This is an important limitation be-
cause it is the precise degree of MR that is being placed into
the equation of analysis for the patient’s long-term survival.
In this era, echocardiography should be the standard for the
diagnosis and evaluation of functional MR.
Additionally, the authors’ conclusion that there was
“progression of the MR” in their patients is difficult to
substantiate because less than one third of the patients had
any echocardiographic follow-up. In fact, this circumstance
might have led to skewing of the follow-up dataset because
those patients with more congestive heart failure might have
been more likely to have been followed with echocardiog-
raphy. Problematically, there is also a lack of granularity in
Dr Mallidi’s analysis of preoperative ventricular function
and clinical status. Because more than half of the patients
had ejection fractions of greater than 40%, it is confusing
why almost 89% of the patients without any MR were
preoperatively categorized in New York Heart Association
class 3 or 4. From this dataset, it still remains unanswered
whether those patients with reduced ventricular function
had poorer outcomes. This is an especially important ques-
tion because it is those patients who are the most important
in this discussion. As Dr Gorman pointed out in his com-
mentary on the Tolis article, ischemic MR can be thought of
as the “ventricle crying out for help.”9
The article by Mallidi and colleagues1 adds to our knowl-
edge as we attempt to deal with this difficult clinical choice.
Our research efforts should remain focused on those pa-
tients with impaired ventricular function, the “sows’ ears”The Journal of Thoracithis patient subset that we might have the capability to
improve outcomes. The question still remains open: In
which patients and with what degree of ischemic MR will
intervention provide improved survival, thereby justifying
an added risk to the operative procedure?
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